Healx is an award-winning start-up based in Cambridge, UK. We closed a healthy seed funding round earlier this year with several ‘Blue Chip’ investors from the Cambridge Cluster (Business Weekly coverage: www.healx.io/news) Furthermore, we were awarded “Life Science Business of the Year” at the 2015 Grand Finale of Cambridge University Entrepreneurs and Carpe Diem Competition.
Back to Healx
We are passionate about identifying next-generation drug development opportunities for rare diseases. In order to achieve this goal, Healx combines in-depth drug repositioning expertise with a cloud-based data analytics platform that combines -omics analysis with data mining and machine learning. Our analysis and interpretation of R&D related datasets helps to identify novel drug development opportunities for rare disease patients. Our unique model engages directly with patient groups and charities, placing them at the heart of the discussion.